| Primary |
| Product Used For Unknown Indication |
13.3% |
| Pain |
12.3% |
| Arthritis |
11.8% |
| Osteoarthritis |
8.4% |
| Back Pain |
7.4% |
| Arthralgia |
6.4% |
| Hypertension |
4.4% |
| Ill-defined Disorder |
3.9% |
| Analgesic Therapy |
3.4% |
| Drug Use For Unknown Indication |
3.4% |
| Rheumatoid Arthritis |
3.4% |
| Fibromyalgia |
3.0% |
| Juvenile Idiopathic Arthritis |
3.0% |
| Chest Pain |
2.5% |
| Joint Sprain |
2.5% |
| Muscle Spasms |
2.5% |
| Myalgia |
2.5% |
| Abdominal Pain |
2.0% |
| Depression |
2.0% |
| Juvenile Arthritis |
2.0% |
|
| Vitreous Haemorrhage |
12.5% |
| Drug Ineffective |
7.5% |
| Renal Failure Acute |
6.3% |
| Vision Blurred |
6.3% |
| Weight Decreased |
6.3% |
| Death |
5.0% |
| Respiratory Arrest |
5.0% |
| Spondylitis |
5.0% |
| Syncope |
5.0% |
| Urticaria |
5.0% |
| Acute Generalised Exanthematous Pustulosis |
3.8% |
| Cutaneous Lupus Erythematosus |
3.8% |
| Drug Hypersensitivity |
3.8% |
| Gastrointestinal Haemorrhage |
3.8% |
| Pain |
3.8% |
| Pallor |
3.8% |
| Rash |
3.8% |
| Weight Increased |
3.8% |
| Wheezing |
3.8% |
| Acute Myocardial Infarction |
2.5% |
|
| Secondary |
| Drug Use For Unknown Indication |
16.0% |
| Product Used For Unknown Indication |
16.0% |
| Headache |
13.7% |
| Rheumatoid Arthritis |
8.0% |
| Bone Disorder |
6.8% |
| Respiratory Disorder |
6.8% |
| Osteoarthritis |
4.3% |
| Pain |
4.1% |
| Ill-defined Disorder |
4.0% |
| Arthritis |
3.4% |
| Back Pain |
2.4% |
| Adenocarcinoma Of Colon |
2.1% |
| Analgesic Therapy |
1.9% |
| Arthralgia |
1.8% |
| Ankylosing Spondylitis |
1.7% |
| Bone Pain |
1.6% |
| Hypertension |
1.5% |
| Juvenile Arthritis |
1.3% |
| Juvenile Idiopathic Arthritis |
1.3% |
| Allergy Test |
1.2% |
|
| Pyrexia |
9.2% |
| Spondylitis |
7.7% |
| Vitreous Haemorrhage |
7.7% |
| Renal Failure Acute |
6.2% |
| Vision Blurred |
6.2% |
| Drug Toxicity |
5.4% |
| Respiratory Arrest |
5.4% |
| Urticaria |
5.4% |
| Death |
4.6% |
| Drug Hypersensitivity |
4.6% |
| Impaired Healing |
4.6% |
| Tonsillitis |
4.6% |
| Toxic Epidermal Necrolysis |
4.6% |
| Completed Suicide |
3.8% |
| Intestinal Diaphragm Disease |
3.8% |
| Pancreatitis Acute |
3.8% |
| Abdominal Pain |
3.1% |
| Atrial Fibrillation |
3.1% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
3.1% |
| Knee Arthroplasty |
3.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.7% |
| Drug Use For Unknown Indication |
19.5% |
| Rheumatoid Arthritis |
15.0% |
| Hypertension |
6.2% |
| Pain |
5.3% |
| Ankylosing Spondylitis |
3.6% |
| Arthritis |
3.3% |
| Multiple Myeloma |
3.1% |
| Depression |
3.0% |
| Psoriatic Arthropathy |
2.3% |
| Prophylaxis |
2.1% |
| Diabetes Mellitus |
1.9% |
| Arthralgia |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Hepatitis C |
1.7% |
| Bipolar Disorder |
1.6% |
| Osteoarthritis |
1.6% |
| Osteoporosis |
1.6% |
| Fibromyalgia |
1.5% |
| Smoking Cessation Therapy |
1.4% |
|
| Vomiting |
13.5% |
| Weight Decreased |
8.7% |
| Weight Increased |
8.7% |
| Pain |
8.1% |
| Myocardial Infarction |
7.4% |
| Pruritus |
4.8% |
| Vision Blurred |
4.8% |
| X-ray Abnormal |
4.5% |
| Type 2 Diabetes Mellitus |
4.2% |
| Somnolence |
3.9% |
| Urinary Tract Infection |
3.5% |
| Depression |
3.2% |
| Drug Ineffective |
3.2% |
| Pain In Extremity |
3.2% |
| Suicidal Ideation |
3.2% |
| Wheezing |
3.2% |
| Deep Vein Thrombosis |
2.9% |
| Injection Site Pain |
2.9% |
| Psoriasis |
2.9% |
| Sinusitis |
2.9% |
|
| Interacting |
| Hypertension |
22.2% |
| Cardiomyopathy |
16.7% |
| Pain |
9.3% |
| Type 2 Diabetes Mellitus |
9.3% |
| Diabetes Mellitus |
7.4% |
| Drug Use For Unknown Indication |
7.4% |
| Tooth Extraction |
7.4% |
| Arteriosclerosis |
3.7% |
| Arthralgia |
3.7% |
| Polyarthritis |
3.7% |
| Analgesia |
1.9% |
| Back Pain |
1.9% |
| Essential Hypertension |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Metabolic Disorder |
1.9% |
|
| Gastrointestinal Haemorrhage |
28.6% |
| Vomiting |
28.6% |
| Renal Failure |
14.3% |
| Intestinal Ulcer |
7.1% |
| Lactic Acidosis |
7.1% |
| Malaise |
7.1% |
| Thinking Abnormal |
7.1% |
|
